Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Raspberry Ketones All Natural Weight Loss Remedy Sells Out In U.S. Health Stores But Is Still Available Online



Raspberry Ketones


(EMAILWIRE.COM, May 18, 2012 ) New York City, NY -- Raspberry ketones have been approved as safe by the U.S. FDA since 1965 and have been used in food to improve taste naturally, but in the last 10 years the all-natural extract of real raspberries has been found to have weight loss effects and energy increase effects. Scientific studies had proven the raspberry ketones would cause mice to lose weight and the general public has been using the ketones this way for 10 years and reporting great results.



Since being advertised on Fox News, raspberry ketones have been selling out in health food stores around the United States, so a British company is now shipping the all-natural health and weight loss supplement to the United States. Those interested in raspberry ketone weight loss can visit the website www.slimmersexpert.com to order the raspberry ketones.



Studies show that it is necessary to take at least 100mg each day of raspberry ketones in order to gain the fat-burning effect. The ketone supplement sold at Slimmers Expert online has this amount of the all-natural weight loss supplement, compared to many ketones on the market which have less than that.



The staff at Slimmers Expert helps people in both Great Britain, the United States and Canada with keeping a supply of the raspberry ketones, which are usually sold out in health food stores.



If one is looking for the raspberry ketone evolution slimming or raspberry ketone plus, or just want a natural organic weight loss remedy, one can order raspberry ketones at the Slimmers Expert website.



About Raspberry Ketones And Slimmer's Expert:



Slimmer's Expert provides healthy and natural weight loss solutions and is a providor of raspberry ketones. Raspberry ketones are the compounds that give raspberries their unique flavor. One of the most important properties of raspberry ketone is that they can help boost metabolism and result in quick and natural weight loss by ensuring faster fat burning in body.

Slimmers Expert
Matt Spenn
(646) - 801 - 7061
mattspenn@gmail.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.


Sanofi confident it can win Medivation shareholders support
29 Apr 2016 at 4:02am

By Matthias Blamont PARIS (Reuters) - Sanofi , which reported higher quarterly profit on Friday boosted by its Genzyme division, is confident Medivation shareholders will back its proposed takeover of the U.S. cancer drug company. The French drugmaker went public on Thursday with a $9.3 billion offer to buy Medivation after it stonewalled its takeover approach, setting up what could be a lengthy battle. "We are confident that Medivation shareholders will ultimately share our strong belief that our offer ... would provide significant and immediate cash value," Sanofi Chief Executive Olivier Brandicourt said on a conference call.



Diabetes drug test results boost Novo Nordisk
29 Apr 2016 at 3:25am

(This April 28 story corrects the fifth paragraph to say that two, not one, other diabetes drugs have positive cardiovascular side-effects) COPENHAGEN (Reuters) - Novo Nordisk said on Thursday a late-stage trial showed its new once-weekly diabetes drug significantly reduced patients' cardiovascular risks, boosting the company's hopes of maintaining its lead in the fast-growing diabetes market. The trial, dubbed SUSTAIN 6, showed the drug - called semaglutide - delivered a "statistically significant reduction in cardiovascular risk" compared with placebo in patients with type 2 diabetes. Cardiovascular risks are often higher among diabetes patients because they tend to be overweight.



AstraZeneca cuts costs and doubles down on cancer drugs
29 Apr 2016 at 3:15am

By Ben Hirschler LONDON (Reuters) - AstraZeneca is to cut costs by $1 billion and increase its focus on cancer treatments after underlying earnings, hit by drug patent expiries, fell 12 percent in the first quarter, broadly in line with analyst expectations. Chief Executive Pascal Soriot said on Friday he would sharpen the prioritization of investments and increase spending in oncology while cutting commercial and manufacturing operations. There will be job losses, reflecting the fact that specialist cancer drugs require smaller sales forces than ones sold to general practitioners.


Reformulated GSK mouthwash endorsed as umbilical cord antiseptic
29 Apr 2016 at 2:01am
By Ben Hirschler LONDON (Reuters) - An antiseptic gel to stop umbilical cord infections in newborn babies was recommended as safe and effective by European regulators on Friday in a boost for GlaxoSmithKline scientists who developed it from a mouthwash. GSK researchers developed the new product by reformulating the chlorhexidine solution found in its popular Corsodyl mouthwash into a gel that can be applied to newly cut umbilical cords. The stump of the umbilical cord can act as an entry point for bacteria, causing life-threatening infections, especially in poorer countries with limited healthcare resources.


Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation
29 Apr 2016 at 1:52am

By Ben Hirschler and Leigh Thomas LONDON/PARIS (Reuters) - French drugmaker Sanofi went public with a $9.3 billion offer to buy Medivation on Thursday, setting up what could be a lengthy takeover battle after the U.S. cancer firm rebuffed its approaches. The decision to target Medivation marks a return to the biotech takeover trail for Sanofi, which is looking to new cancer treatments to bolster its portfolio and help offset declining sales of mainstay diabetes drug Lantus. Sanofi's non-binding proposal is to buy Medivation for $52.50 per share in cash, representing a roughly 36 percent premium over Medivation's stock price one month prior to Thursday's offer.



Hackett says drink not drugs behind mile high meltdown
29 Apr 2016 at 12:33am

Australian long distance swimming great Grant Hackett has admitted that binge drinking was behind his altercation with another passenger on a flight earlier this month and said he was seeking help to quit alcohol. The 35-year-old former Olympic champion was spoken to by police after the incident on a flight from the Australian Olympic trials in Adelaide to Melbourne. Hackett has admitted to a dependence on prescription drugs in the past but said on Friday that the incident on the plane had come after he had been drinking in the wake of his failure to secure a spot on the team for this year's Rio Olympics.


Swimming-Hackett says drink not drugs behind mile high meltdown
29 Apr 2016 at 12:22am
Australian long distance swimming great Grant Hackett has admitted that binge drinking was behind his altercation with another passenger on a flight earlier this month and said he was seeking help to quit alcohol. The 35-year-old former Olympic champion was spoken to by police after the incident on a flight from the Australian Olympic trials in Adelaide to Melbourne. Hackett has admitted to a dependence on prescription drugs in the past but said on Friday that the incident on the plane had come after he had been drinking in the wake of his failure to secure a spot on the team for this year's Rio Olympics.


Liberian soccer star-turned-politician Weah to run for president
29 Apr 2016 at 12:03am

By James Harding Giahyue CONGO TOWN, Liberia (Reuters) - Liberian international soccer star-turned-politician George Weah said on Thursday he will make a second bid for the presidency of the impoverished West African nation in an election next year. Chanting "You can have the whole world but give me Weah," thousands of his backers packed onto the grounds of his Congress for Democratic Change (CDC) headquarters in the capital, Congo Town, to listen to the announcement. Liberia has spent more than a decade rebuilding from a long civil war that ended in 2003 and decimated infrastructure in the nation founded in the 19th century by freed American slaves.


Iran moderates eye more gains in run-off parliamentary election
29 Apr 2016 at 4:13am

By Parisa Hafezi ANKARA (Reuters) - Iranians lined up outside polling stations on Friday to vote in a second round of parliamentary elections, with allies of reformist President Hassan Rouhani seeking to wrest more seats from hardliners. Rouhani's moderate and centrist allies made big gains in elections on Feb. 26 for parliament and a clerical body that will elect the next Supreme Leader, but they failed to win a majority of the 290-member assembly. ...



Japan's corpse hotels upset some of the neighbors
28 Apr 2016 at 10:29pm

Tucked away in a quiet residential street in Kawasaki city in Japan is a refurbished workshop with a plain silver exterior and black draped windows that residents describe as creepy. The business inside, Sousou, is one of Japan's latest so-called corpse hotels, a camouflaged morgue used to store some of Japan's mounting pile of bodies waiting for a spot in one of the nation's overworked crematoriums. ?Crematories need to be built, but there isn?t any space to do so and that is creating funeral refugees," said Hisao Takegishi, who opened the business in 2014.



FBI paid under $1 million to unlock San Bernardino iPhone: sources
28 Apr 2016 at 6:25pm

By Mark Hosenball WASHINGTON (Reuters) - The FBI paid under $1 million for the technique used to unlock the iPhone used by one of the San Bernardino shooters - a figure smaller than the $1.3 million the agency's chief initially indicated the hack cost, several U.S. government sources said on Thursday. The Federal Bureau of Investigation will be able to use the technique to unlock other iPhone 5C models running iOS 9 - the specifications of the shooter's phone - without additional payment to the contractor who provided it, these people added. FBI Director James Comey last week said the agency paid more to get into the iPhone than he will make in the remaining seven years and four months he has in his job, suggesting the hack cost over $1.3 billion, based on his annual salary.



Wall Street sinks on BOJ fears, Icahn comments
28 Apr 2016 at 6:02pm

The benchmark S&P 500 had its worst day in three weeks, losing 19.34 points, or 0.92 percent, to 2,075.81, the Dow Jones industrial average fell 210.79 points, or 1.17 percent, to 17,830.76 and the Nasdaq Composite dropped 57.85 points, or 1.19 percent, to 4,805.29. Wall Street dipped further late in the day, led by a decline in Apple stock. Shares of Apple, already suffering from disappointing earnings, took another hit after billionaire investor Carl Icahn said he no longer has a position.


GAO: Health care access hard to measure for Native Americans
28 Apr 2016 at 5:51pm
FLAGSTAFF, Ariz. (AP) ? Access to health care for American Indians is difficult to gauge because the agency that oversees it does a poor job of tracking patient wait times, a report by a federal watchdog found.

Hawaii looks to allow psychologists to prescribe drugs
28 Apr 2016 at 5:42pm
HONOLULU (AP) ? State lawmakers are poised to make Hawaii one of a handful of states that allow psychologists to prescribe medication in hopes of increasing access to mental health services.


Quest Diagnostics says its Zika virus test gets U.S. approval
28 Apr 2016 at 5:26pm

(Reuters) - Quest Diagnostics Inc said it has received emergency authorization from the U.S. Food and Drug Administration to sell the first commercially developed diagnostic test for Zika in the United States, a step that may help expand testing capacity and speed diagnosis of the virus. Previously, the only Zika blood tests that had Emergency Use Authorization, or EUA, were available from the U.S. Centers for Disease Control and Prevention and were only to be used in qualified laboratories designated by the CDC. Quest, in its announcement on Thursday, said it plans to make the new test broadly available to doctors for patient testing, including in Puerto Rico, by early next week.


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC